Rajeev Saggar
Direttore Tecnico/Scientifico/R&S presso LIQUIDIA CORPORATION
Patrimonio netto: 3 M $ in data 30/04/2024
Posizioni attive di Rajeev Saggar
Società | Posizione | Inizio | Fine |
---|---|---|---|
LIQUIDIA CORPORATION | Direttore Tecnico/Scientifico/R&S | 18/07/2022 | - |
Storia della carriera di Rajeev Saggar
Precedenti posizioni note di Rajeev Saggar
Società | Posizione | Inizio | Fine |
---|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/09/2021 | 01/07/2022 |
The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Formazione di Rajeev Saggar
University of California, Irvine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Rajeev Saggar
- Esperienza